Postdoctoral Researcher for the Hematovascular Pathophysiology Laboratory

The Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (CNIC) was established to conduct excellent, competitive research of international relevance in the field of cardiovascular diseases. CNIC has a 24,000 m² research center located in Madrid, including more than 6,000 m² of laboratory space equipped with state-of-the-art infrastructure and cutting-edge technology.

A position is open for a Postdoctoral Researcher to work in the Hematovascular Pathophysiology Group, under the supervision of Dr. José Javier Fuster Ortuño.

More information:

https://www.cnic.es/en/investigacion/hematovascular-pathophysiology

This contract is part of the project “Precision Biomarkers for Improving the Diagnosis and Treatment of Inflammatory Myocardial Disease (PreMyo)”, reference PMP22/00105, funded by the Instituto de Salud Carlos III and co-funded by the European Union – NextGenerationEU, within the call for “Proyectos de Investigación de Medicina Personalizada de Precisión (PMP 2022)”.

Functions:

The selected candidate will work under the supervision of Dr. José Javier Fuster and will carry out studies within the framework of the project “Biomarcadores de precisión para la mejora del diagnóstico y tratamiento de la enfermedad inflamatoria del miocardio (PreMyo)”. The selected researcher will be responsible for the analysis of genotyping and DNA sequencing data generated in the project using Next Generation Sequencing (NGS) technologies. This includes bioinformatic analysis of sequencing data, curation of somatic genetic variants associated with clonal hematopoiesis, and statistical analysis of their relationship with the development of inflammatory myocardial disease.

Mandatpry Requirements:

1. PhD degree in a scientific field related to life sciences or biomedical research.
2. Minimum of 4 years of previous experience in research laboratories (2 years and 8 months for disabled people greater than 66% and 3 years and 4 months for disabled people greater than 33%).
3. At least one first-author publication (the CV must include a complete list of publications, detailing journal name, authors, and journal impact factor).

Evaluable Criteria:

• C1. Previous experience in cardiovascular research in the context of atherosclerosis, heart failure, and/or myocarditis.
• C2. Previous experience in hematology research, specifically in the field of clonal hematopoiesis.
• C3. Previous experience in projects involving the detection of low-frequency somatic mutations using massive NGS sequencing techniques.
• C4. Previous experience in statistical and bioinformatic analysis of omics data in large human cohorts.
• C5. Interview.

Positive action: A correction factor of 1.5 per year of experience will be applied when assessing the total years of experience in criteria where experience is evaluated, in cases where the candidate certifies a disability greater than 66%, and a factor of 1.2 where the candidate certifies a disability greater than 33%.

We Offer:

• Integration into a research center of international relevance in the scientific field.
• Access to state-of-the-art technological infrastructure.
• Integration into young teams within an environment of scientific excellence.
• Immediate start date.
• Postdoctoral research contract of 3 years duration, extendable up to the maximum limit of 6 years, in accordance with Art. 22 Law of Science, Technology and Innovation (texto refundido Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la Innovación), linked to the project “Precision Biomarkers for Improving the Diagnosis and Treatment of Inflammatory Myocardial Disease (PreMyo)” (reference PMP22/00105), funded by the Instituto de Salud Carlos III and co-funded by the European Union – NextGenerationEU, under the Proyectos de Investigación de Medicina Personalizada de Precisión” 2022 call, as long as the selected candidate complies with the legal requirements for the formalization of the contract in accordance with the Spanish labor law.

Recruiment Plan:

The RESOLUTION OF THE SECRETARIAT OF STATE FOR PUBLIC FUNCTION APPROVING THE COMMON ACTION CRITERIA FOR THE RECRUITMENT PROCESSES IN THE STATE PUBLIC SECTOR ENTITIES of April 11, 2022, sets forth in point 6.1 that “Unless a specific regulation establishes a merit-bases recruitment system (“concurso”), the competition (“concurso-oposición”) must be the recruitment system”.

In CNIC, the specific regulations approved by the Foundation's board of trustees establish a merit-based recruitment system (“concurso”) including a personal interview.

At least the 3 candidates with the highest score, as long as they reach the minimum of 65 points as a sum of criteria (C1-C4), will be interviewed.  The three candidates with the highest score will be hired given the candidate reaches at least total score (C1-C5) of 80 points.

Recruitment Commission:

• Head of Hematovascular Pathophysiology group.
• Research Office Manager
• Research Office Manager
• HR Member

The CNIC guarantees, within its scope of action, the principle of equal access to employment, and may not establish any direct or indirect discrimination based on grounds of origin, including racial or ethnic origin, sex, age, marital status, religion or beliefs, political opinion, sexual orientation and identity, gender expression, sexual characteristics, trade union membership, social status, language within the State and disability, provided that the workers are fit to perform the work or job in question.

By participating in the selection process, the participant accepts that their data appear in the public resolutions of the selection process. Such resolutions (provisional list of admitted and excluded, definitive list of admitted and excluded and resolution of the process) are published on the CNIC website.